Global Oncology Academy

Detecting ESR1 Mutations in Metastatic Breast Cancer: The Role of Liquid Biopsies

ReachMD Healthcare Image
RestartResume

Explore the important role liquid biopsies play in detecting ESR1 mutations in patients with metastatic breast cancer.

Take Post-Survey

If you’ve already completed the activity.

  • Overview

    Acquired ESR1 mutations cannot be detected on archival tissue and require liquid biopsy. Fortunately, this approach circumvents the challenges of acquiring serial tissue while allowing for the real-time monitoring of ESR1 status in patients with metastatic breast cancer. Learn more about the rationale behind liquid biopsies and best practices for utilizing them in clinical practice with Dr. Charles Turck and Dr. Pavani Chalasani, Division Director of Hematology-Oncology at the GW Cancer Center in Washington, DC.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free